Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Not Available].

S Sabbatani1, A Ferro, V Gomes

  • 1Divisione Malattie Infettive, Ospedale Maggiore, Bologna.

Le Infezioni in Medicina
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

ESMO real world data and digital oncology·2026
Same author

A fully 3D-printed contoured double passive scattering system for ultra-high-dose-rate irradiations.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2026
Same author

Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial.

ESMO open·2025
Same author

A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Thin segmented silicon detectors for single ion tracking in carbon ion beam therapy: Performance insights.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2025
Same author

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)].

ESMO open·2024
Same journal

Rezafungin and catheter-related candidemia: a new player in a high-stakes game.

Le infezioni in medicina·2026
Same journal

Effectiveness and Safety Profile of BIC/TAF/FTC in People living with HIV Switched from Other Antiretroviral Regimens: A Real-Life Retrospective Cohort Analysis.

Le infezioni in medicina·2026
Same journal

Insights into parvovirus B19 clinical and virological dynamics among blood donors.

Le infezioni in medicina·2026
Same journal

When Faster Diagnosis Is Not Enough: Bringing Diagnostic Stewardship into Antimicrobial Stewardship.

Le infezioni in medicina·2026
Same journal

Fragility of Immunisation and Water Systems in Gaza: Infectious Disease Risks in a Conflict-Affected Setting.

Le infezioni in medicina·2026
Same journal

HIV-2 infection in Europe - persistence by migrant flows from West Africa but low spillover into the native population.

Le infezioni in medicina·2026
See all related articles

Tuberculosis patients in Guinea Bissau show a 20% prevalence of HIV-2, with increasing HIV-1 cases. HIV-2 co-infection appears to correlate with longer survival times compared to HIV-1.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Context:

  • Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) co-infection is a significant global health challenge, particularly in sub-Saharan Africa.
  • Guinea Bissau faces a dual burden of TB and HIV, necessitating understanding of their epidemiological interplay and patient outcomes.
  • Limited data exists on the specific epidemiological status and therapeutic follow-up of TB patients co-infected with HIV-1 and HIV-2 in this region.

Purpose:

  • To report the epidemiological status of HIV-1 and HIV-2 infections among tuberculosis patients in Guinea Bissau.
  • To evaluate the therapeutic follow-up and survival times of patients co-infected with tuberculosis and HIV-2.
  • To analyze survival determinants including sex, sputum positivity, and age range.

Summary:

Related Experiment Videos

  • The study reports a serum prevalence of approximately 20% for HIV-2 among tuberculosis patients in Guinea Bissau, with a recent increase in HIV-1 infections.
  • Survival analysis using the Kaplan-Meier curve for 177 co-infected patients (TB-HIV-2) showed no significant difference based on sex.
  • TB-HIV-2 co-infected patients demonstrated longer survival compared to TB-HIV-1 patients, based on available European and North American data.

Impact:

  • Provides crucial epidemiological data on TB-HIV co-infection in Guinea Bissau, informing regional public health strategies.
  • Highlights potential differences in survival outcomes between HIV-1 and HIV-2 co-infections in a West African setting.
  • Underscores the need for further research correlating immunological and microbiological data with clinical outcomes, despite financial constraints.